Literature DB >> 2427350

Expression of extracellular matrix genes in relation to myogenesis and neoplastic transformation.

S A Leibovitch, J Hillion, M P Leibovitch, M Guillier, A Schmitz, J Harel.   

Abstract

Fibronectin and alpha 1(I) and alpha 2(I) collagen proteins and RNAs are highly expressed during the growth phase of the non-transformed L6 alpha 1 rat myoblasts. When L6 alpha 1 cells from myotubes following transfer to low serum medium, the levels of fibronectin RNA decrease 8-fold, those of both alpha 2(I) transcripts decrease only 2-fold, while those of both alpha 1(I) transcripts remain stable. The L6 alpha 1 cell-derived non-differentiable low-malignant M4 cell and high-malignant RMS4 cell display only one size of alpha 1(I) and alpha 2(I) transcripts. Compared with L6 alpha 1 myoblasts, the levels of fibronectin and alpha 1(I) RNAs are reduced by factors of 4-5 and 9-10 respectively in both M4 and RMS4 and those of alpha 2(I) RNAs by factors of 10-11 and 20-22 in M4 and RMS4, respectively. Transcription rates are similarly decreased for fibronectin RNA, but are decreased less for collagen RNAs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427350     DOI: 10.1016/0014-4827(86)90497-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  3 in total

1.  Collagen production by human smooth muscle cells isolated during intestinal organogenesis.

Authors:  H A Perr; J R Grider; A S Mills; M Kornstein; D A Turner; R F Diegelmann; M F Graham
Journal:  Anat Embryol (Berl)       Date:  1992

2.  Organization of the fibronectin gene provides evidence for exon shuffling during evolution.

Authors:  R S Patel; E Odermatt; J E Schwarzbauer; R O Hynes
Journal:  EMBO J       Date:  1987-09       Impact factor: 11.598

3.  Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone.

Authors:  A E Grigoriadis; J N Heersche; J E Aubin
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.